Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2149 of 6351
-
Immune 'hotness' and growth markers may sharpen lymphoma prognosis
Knowledge-focused Not yet recruitingDiffuse large B-cell lymphoma (DLBCL) is the most common aggressive non-Hodgkin lymphoma with heterogeneity in its clinical presentations, biological behaviour and response to therapy (1-4). Nevertheless, despite R-CHOP chemotherapy being successful, a high percentage of patients…
Sponsor: Sohag University • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Heart surgery breakthrough? amino acid infusion may shield kidneys
Prevention Not yet recruitingThe goal of this study is to see if an infusion of amino acids given to adult male and female patients during cardiac surgery can help prevent acute kidney injury that commonly occurs when patients undergo cardiac surgery needing cardiopulmonary bypass. The main question the stud…
Phase 4 • Sponsor: Milton S. Hershey Medical Center • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
Can a smartphone app improve schizophrenia care in India's villages?
Disease control Not yet recruitingSchizophrenia represents a significant contributor to the global burden of disease, with this burden disproportionately impacting low- and middle-income countries (LMICs). In India, the burden due to schizophrenia is further exacerbated by low access to effective psychosocial int…
Sponsor: Harvard Medical School (HMS and HSDM) • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Scientists grow penile tissue in lab for first human trial
Disease control Not yet recruitingThe primary objective of this clinical trial is to evaluate the safety of autologous engineered corpora cavernosa + albuginea constructs for treatment of complex penile deformities. Autologous endothelial and smooth muscle cells obtained from enrolled subjects' corpora cavernosa …
Phase 1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Migraine drug NURTEC under Real-World safety watch in korea
Symptom relief Not yet recruitingThe purpose of this study is to evaluate safety and effectiveness of NURTEC® ODT 75 mg (Rimegepant sulfate) in adult patients with acute treatment of migraine with or without aura and with preventive treatment of episodic migraine during the PMS period as required by the Korean m…
Sponsor: Pfizer • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Blood test could revolutionize rectal cancer monitoring
Knowledge-focused Not yet recruitingThis prospective observational, non-therapeutic study for patients with T3, T4, or node positive rectal cancer eligible to undergo total neoadjuvant therapy. This research study involves the collection of data and biospecimens (blood and tissue) to see if the presence of circula…
Sponsor: Massachusetts General Hospital • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
New shot aims to melt belly fat without surgery
Symptom relief Not yet recruitingA phase 3, randomized, double-blinded, placebo-controlled study to evaluate the efficacy, safety, and tolerability of CBL-514 injection for reducing abdominal subcutaneous fat.
Phase 3 • Sponsor: Caliway Biopharmaceuticals Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Could a simple ultrasound biopsy replace surgery for breast cancer staging?
Diagnosis Not yet recruitingThis study plans to find the most suitable lymph node cortex thickness and abnormal lymph node features to define suspicious lymph nodes. Then, ultrasound-guided core needle biopsy of axillary lymph nodes will be done, aiming to provide some guidance for the biopsy.
Sponsor: The First Hospital of Jilin University • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
New toolkit aims to boost PrEP access for youth in alabama and botswana
Prevention Not yet recruitingThis study evaluates strategies to improve access to HIV prevention through the integration of pre-exposure prophylaxis (PrEP) into existing healthcare settings, rather than limiting delivery to specialty clinics. The study addresses barriers to PrEP uptake, including limited awa…
Sponsor: University of Alabama at Birmingham • Aim: Prevention
Last updated Sep 05, 2026 00:00 UTC
-
Can lung patients ditch their meds after procedure? new trial investigates
Disease control Not yet recruitingChronic thromboembolic pulmonary hypertension (CTEPH) is a rare but severe complication of acute pulmonary embolism, characterized by persistent obstruction of the pulmonary arteries by organized thrombi and secondary microvasculopathy. International guidelines recommend a multim…
Phase 3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Tiny device could fix leaky heart valves without cutting chest open
Disease control Not yet recruitingThe goal of this clinical trial is to generate initial human clinical experience and evaluate procedural feasibility, device deployment, and early safety under controlled First-In-Human conditions for the Anchord Mitral Chordal Repair System in patients with degenerative mitral r…
Sponsor: Lifecord Otd • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a skin biopsy reveal how axatilimab fights scarring in chronic GVHD?
Knowledge-focused Not yet recruitingChronic graft-versus-host disease (cGVHD) is a condition that can develop after a stem cell transplant. It occurs when donor immune cells attack the body's tissues. In many people, cGVHD affects the skin, causing inflammation, thickening, and scarring that can limit movement and …
Sponsor: Northwestern University • Aim: Knowledge-focused
Last updated Aug 14, 2026 00:00 UTC
-
Could a 16-Week home exercise program change the course of early MS?
Symptom relief Not yet recruitingThe proposed study is a parallel-group randomized controlled trial (RCT) designed to establish the behavioral mechanism underlying a 16-week physical activity (PA) behavioral intervention through its effects on the Capability-Opportunity-Motivation-Behavior (COM-B) constructs. Th…
Sponsor: University of Illinois at Chicago • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Talking through pain: could emotional awareness therapy help those on medical cannabis?
Symptom relief Recruiting nowThe goal of this clinical trial is to evaluate whether a culturally adapted, virtual, group-based emotional therapy called Emotional Awareness and Expression Therapy is feasible and whether it can help reduce chronic pain and improve emotional well-being among Israeli adults who …
Sponsor: Reuth Rehabilitation Hospital • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Frown lines under fire: new injection aims to erase Between-Brow wrinkles
Symptom relief Not yet recruitingThe purpose of this study is to find out about the effectiveness and safety of a single dose of corabotase (also known as IPN10200) compared to placebo works in participants with moderate to severe glabellar lines. Glabellar lines are wrinkle-like lines that appear between the ey…
Phase 3 • Sponsor: Ipsen • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
Ultrasound before induced labor may reveal delivery risks
Knowledge-focused Not yet recruitingPregnancy and vaginal birth are the main causes of pelvic floor disorders such as urinary incontinence and pelvic organ prolapse. The levator hiatus - the opening in the pelvic floor muscles through which the baby passes - can be measured on three-dimensional transperineal ultras…
Sponsor: University of Roma La Sapienza • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Can an arthritis drug keep HIV in check without daily pills?
Disease control Not yet recruitingThis study is being done to test whether a drug called baricitinib, which blocks specific causes of inflammation, affects HIV-1 viral rebound and viral load levels after HIV treatment is discontinued. Researchers will test the effects of continuing baricitinib in people with HIV …
Phase 2 • Sponsor: Emory University • Aim: Disease control
Last updated Aug 19, 2026 00:00 UTC
-
Can a Lab-Grown artery graft outlast current options?
Disease control Not yet recruitingSingle center, single arm study to evaluate the Safety and Efficacy of LineMatrix® Biological Vascular Graft for Infra-renal Arterial Bypass or Replacement
Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Aug 01, 2026 00:00 UTC
-
Could eye drops replace injections for a leading cause of blindness?
Knowledge-focused Not yet recruitingThe goal of this clinical trial is to learn about the safety, tolerability, and systemic pharmacokinetics of PAN-90806 eye drops in healthy adults. It will also evaluate what medical problems participants may have when taking PAN-90806. The main questions it aims to answer are: …
Phase 1 • Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd. • Aim: Knowledge-focused
Last updated Aug 16, 2026 00:00 UTC
-
Could a new injection help tackle obesity? a safety trial begins
Disease control Not yet recruitingTo evaluate the safety and tolerability of SYH2092 Injection in healthy participants
Phase 1 • Sponsor: CSPC Megalith Biopharmaceutical Co.,Ltd. • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC